obesity-2016_keynote

4 / 11

Volume 6, Issue 9(Suppl) J Obes Weight Loss Ther 2016
ISSN: 2165-7904 JOWT, an open access journal Obesity 2016
December 08-10, 2016
Page 18
Notes:
conferenceseries.com
Obesity & Weight Management
December 08-10, 2016 Dallas, USA
10th International Conference and Exhibition on
Towards individualized therapy for obesity: A heterogeneous disorder
Obesity is a heterogeneous disorder of various causes. To make treatment most effective, therapy must be tailored to
individuals who manifest obesity with different underlying etiologies. Monogenic forms of obesity are rare, but some of
them where correction of the underlying defect is attainable provide opportunities for showcasing individualized treatment
principles and favorable outcomes. The common forms of obesity are polygenic in nature. While the exact genetic defects in
the affected individuals are not known, most of them manifest as predominantly metabolic obesity or hedonic obesity, which
should be treated differentially with tailored interventions whenever possible. More importantly at this time, we advocate that
existing therapies and treatment modalities under development be evaluated for their optimal therapeutic efficacy separately
in patients with metabolic obesity and those with hedonic obesity.
Biography
Yi-Hao Yu is an Endocrinologist of Northeast Medical Group, Yale-New Haven Health System, Connecticut, USA. He is the Medical Director of Center for Behavioral
& Nutrition Health and Inpatient Diabetes Program at Greenwich Hospital. Previously, he was faculty of several universities and served as Director of Nutrition
Services at Columbia Presbyterian Hospital, Director of Nutrition Fellowship Program at Columbia University and Medical Director of Discovery Medicine & Clinical
Pharmacology at Bristol-Myers Squibb Company. He completed his MD and PhD at NYU School of Medicine. He has published more than 20 original research
papers in the top-notch medical and scientific journals and many reviews/book chapters in the field of “Diabetes, obesity and associated metabolic disorders”.
Yi-Hao Yu
Greenwich Hospital, USA
Yi-Hao Yu, J Obes Weight Loss Ther 2016, 6:9(Suppl)